$2950 | Single User
$5900 | Site License
$8850 | Enterprise License

Chronic Heart Failure - Epidemiology Insights to 2025 [Report Updated: 10-07-2017]

Published by Delve Insight: 10 Jul 2017 | 105498 | In Stock

Introduction

DelveInsight “ Chronic Heart Failure - Epidemiology Forecast To 2025” provides an overview of the epidemiology trends of Chronic Heart Failure in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Chronic Heart Failure prevalent or incident cases segmented by age, sex and subpopulations. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical need associated with the Chronic Heart Failure. The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by DelveInsight team of industry experts.

Scope of the Report

The Report includes the prevalent population and how will it change over the next eight years.

Prevalent or incident cases segmented by age and sex.

Coverage of key Chronic Heart Failure subpopulations and its prevalent or incident cases

The key differences in epidemiology patterns across the seven market segments

Key Coverage and Benefits

The report will help in developing business strategies by understanding the trends shaping and driving the global Chronic Heart Failure market.

Identifying prevalent patient populations as well as risk factors in the global Chronic Heart Failure market will help to improve product design, pricing, and launch plans.

Organize sales and marketing efforts by identifying the best opportunities for Chronic Heart Failure therapeutics in each of the markets covered.

Chronic Heart Failure Disease Overview

Chronic Heart Failure Prevalence

Chronic Heart Failure Incidence

Chronic Heart Failure Risk Factors

Chronic Heart Failure Epidemiology

Chronic Heart Failure Patient Populations

Chronic Heart Failure Diagnosed Patients

Chronic Heart Failure Forecast

Chronic Heart Failure Epidemiology Forecast

Chronic Heart Failure Treated patients/population

Table of Contents
for Chronic Heart Failure - Epidemiology Insights to 2025 [Report Updated: 10-07-2017]

  • Report Introduction

    Snapshot of Total Prevalent or Incident cases by 7 MM

    Executive Summary

    Key Findings

    Chronic Heart Failure

    Overview

    Chronic Heart Failure Definition

    Pathophysiology

    Symptoms

    Etiology

    Risk Factors Associated with Chronic Heart Failure

    Disease Burden & Unmet Need in the Market

    Epidemiology and Patient Populations

    Key Findings

    Key Sources used and Forecast Methodology

    Prevalent Cases and Incident Cases-2015-2025

    Prevalent & Incident Cases by Category-2015-2025

    Age-Specific Prevalent/ Incident Cases of Chronic Heart Failure

    Sex-Specific Prevalent/Incident Cases Chronic Heart Failure

    Disease Type Specific Prevalent/Incident Cases of Chronic Heart Failure

    Prevalent & Incident Cases by 7 MM-2015-2025

    Chronic Heart Failure Epidemiology of United States-2025

    Chronic Heart Failure Epidemiology of United Kingdom-2025

    Chronic Heart Failure Epidemiology of Germany-2025

    Chronic Heart Failure Epidemiology of France-2025

    Chronic Heart Failure Epidemiology of Spain-2025

    Chronic Heart Failure Epidemiology of Italy-2025

    Chronic Heart Failure Epidemiology of Japan-2025.

    Key Takeaways

    Appendix

    Report Methodology

    Consulting Services

    Disclaimer

    About Us

List Of Tables
in Chronic Heart Failure - Epidemiology Insights to 2025 [Report Updated: 10-07-2017]

Table 1: Clinical subtypes of Indication

Table 2: Risk Factors

Table 3: Prevalence cases (%) Region wise

Table 4: Sources used for forecasting the data

Table 5: Chronic Heart Failure Global Epidemiology, (2015-2025)

Table 6: Prevalent Cases of Chronic Heart Failure (Ages =XX Years), US (2015-2025)

Table 7: Prevalent Cases of Chronic Heart Failure By Sex (Males & Females), US (2015-2025)

Table 8: Prevalent Cases By Chronic Heart Failure Sub-population, US (2015-2025)

Table 9: Prevalent Cases of Chronic Heart Failure (Ages =XX Years), United Kingdom (2015-2025)

Table 10: Prevalent Cases of Chronic Heart Failure By Sex (Males & Females), United Kingdom (2015-2025)

Table 11: Prevalent Cases By Chronic Heart Failure Sub-population, United Kingdom (2015-2025)

Table 12: Prevalent Cases of Chronic Heart Failure (Ages =XX Years), Germany (2015-2025)

Table 13: Prevalent Cases of Chronic Heart Failure By Sex (Males & Females), Germany (2015-2025)

Table 14: Prevalent Cases By Chronic Heart Failure Sub-population, Germany (2015-2025)

Table 15: Prevalent Cases of Chronic Heart Failure (Ages =XX Years), France (2015-2025)

Table 16: Prevalent Cases of Chronic Heart Failure By Sex (Males & Females), France (2015-2025)

Table 17: Prevalent Cases By Chronic Heart Failure Sub-population, France (2015-2025)

Table 18: Prevalent Cases of Chronic Heart Failure(Ages =XX Years), Italy (2015-2025)

Table 19: Prevalent Cases of Chronic Heart Failure By Sex (Males & Females), Italy (2015-2025)

Table 20: Prevalent Cases By Chronic Heart Failure Sub-population, Italy (2015-2025)

Table 21: Prevalent Cases of Chronic Heart Failure (Ages =XX Years), Spain (2015-2025)

Table 22: Prevalent Cases of Chronic Heart Failure By Sex (Males & Females), Spain (2015-2025)

Table 23: Prevalent Cases By Chronic Heart Failure Sub-population, Spain (2015-2025)

Table 24: Prevalent Cases of Chronic Heart Failure (Ages =XX Years), Japan (2015-2025)

Table 25: Prevalent Cases of Chronic Heart Failure By Sex (Males & Females), Japan (2015-2025)

Table 26: Prevalent Cases By Chronic Heart Failure Sub-population, Japan (2015-2025)

List Of Figures, Charts and Diagrams
in Chronic Heart Failure - Epidemiology Insights to 2025 [Report Updated: 10-07-2017]

Figure 1: Prevalence cases (%) Region wise

Figure 2: Sources used for forecasting the data

Figure 3: Chronic Heart Failure Global Epidemiology, (2015-2025)

Figure 4: Prevalent Cases of Chronic Heart Failure (Ages =XX Years), US (2015-2025)

Figure 5: Prevalent Cases of Chronic Heart Failure By Sex (Males & Females), US (2015-2025)

Figure 6: Prevalent Cases By Chronic Heart Failure Sub-population, US (2015-2025)

Figure 7: Prevalent Cases of Chronic Heart Failure (Ages =XX Years), United Kingdom (2015-2025)

Figure 8: Prevalent Cases of Chronic Heart Failure By Sex (Males & Females), United Kingdom (2015-2025)

Figure 9: Prevalent Cases By Chronic Heart Failure Sub-population, United Kingdom (2015-2025)

Figure 10: Prevalent Cases of Chronic Heart Failure (Ages =XX Years), Germany (2015-2025)

Figure 11: Prevalent Cases of Chronic Heart Failure By Sex (Males & Females), Germany (2015-2025)

Figure 12: Prevalent Cases By Chronic Heart Failure Sub-population, Germany (2015-2025)

Figure 13: Prevalent Cases of Chronic Heart Failure (Ages =XX Years), France (2015-2025)

Figure 14: Prevalent Cases of Chronic Heart Failure By Sex (Males & Females), France (2015-2025)

Figure 15: Prevalent Cases By Chronic Heart Failure Sub-population, France (2015-2025)

Figure 16: Prevalent Cases of Chronic Heart Failure (Ages =XX Years), Italy (2015-2025)

Figure 17: Prevalent Cases of Chronic Heart Failure By Sex (Males & Females), Italy (2015-2025)

Figure 18: Prevalent Cases By Chronic Heart Failure Sub-population, Italy (2015-2025)

Figure 19: Prevalent Cases of Chronic Heart Failure (Ages =XX Years), Spain (2015-2025)

Figure 20: Prevalent Cases of Chronic Heart Failure By Sex (Males & Females), Spain (2015-2025)

Figure 21: Prevalent Cases By Chronic Heart Failure Sub-population, Spain (2015-2025)

Figure 22: Prevalent Cases of Chronic Heart Failure (Ages =XX Years), Japan (2015-2025)

Figure 23: Prevalent Cases of Chronic Heart Failure By Sex (Males & Females), Japan (2015-2025)

Figure 24: Prevalent Cases By Chronic Heart Failure Sub-population, Japan (2015-2025)

Additional Details

Publisher

Delve Insight

Publisher Information

DelveInsight is a leading Business Consulting and Market Research Firm. We combine industry expertise with probing market insights in innovative ways to deliver enduring results to deliver critical information to leading decision makers.



We help our clients to find answers relevant to their business, facilitating decision-making; identify potential market opportunities, competitor assessments and business environmental assessment. DelveInsight is a knowledge partner for business strategy and market research across the drug value chain.

Reference

105498 | DIEI0054

Number of Pages

40

Report Format

PDF

Delve Insight Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Global Acute and Chronic Myelogenous Leukemia Partnering 2010 to 2016
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and acce...
01 Oct 2016 by Current Partnering USD $1,495 More Info
Global Chronic Kidney Disease Partnering 2010 to 2016
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and acce...
01 Oct 2016 by Current Partnering USD $1,495 More Info
The Outlook for Wearable Health Tech in Managing Chronic Disease
IntroductionWearable tech – the new golden ticket for patient adherence?Wearable technology is being...
01 May 2016 by FirstWord Pharma USD $695 More Info
Chronic Obstructive Pulmonary Disorder (COPD): Update Bulletin [Feb 2016]
IntroductionThis edition presents key opinion leader (KOL) views on recent developments in the chron...
01 Feb 2016 by FirstWord Pharma USD $995 More Info
Chronic Lymphocytic Leukaemia: Update Bulletin [Feb 2016]
IntroductionGain new KOL insights on the latest events with the potential to shape the targeted trea...
01 Feb 2016 by FirstWord Pharma USD $995 More Info
Chronic Lymphocytic Leukaemia: KOL Insight
IntroductionIn the last few years the emergence of new targeted therapies such as AbbVie’s/Janssen’s...
01 Sep 2015 by FirstWord Pharma USD $7,900 More Info
Chronic Obstructive Pulmonary Disorder (COPD): KOL Insight
IntroductionCombination therapy is set to take centre stage in the treatment of COPD as leading comp...
20 Apr 2015 by FirstWord Pharma USD $7,900 More Info
Chronic Lymphocytic Leukaemia: KOL Insight
IntroductionChronic lymphocytic leukaemia (CLL) is the most common of the leukaemias, but until rece...
27 May 2014 by FirstWord Pharma USD $7,900 More Info
Chronic Obstructive Pulmonary Disorder (COPD) - KOL Insight and Consensus Outlook
IntroductionThe prevalence of Chronic Obstructive Pulmonary Disorder (COPD) is increasing globally, ...
20 Jan 2014 by FirstWord Pharma USD $7,495 More Info
Physician Views: Life after Gleevec in the chronic myeloid leukaemia (CML) market?
ScopeNovartis' Gleevec is widely credited as being one of the most important drug launches of all ti...
01 Jun 2013 by FirstWord Pharma USD $695 More Info

This report is published by Delve Insight

DelveInsight is a leading Business Consulting and Market Research Firm. We combine industry expertise with probing market insights in innovative ways to deliver enduring results to deliver critical information to leading decision makers.

We help our clients to find answers relevant to their business, facilitating decision-making; identify potential market opportunities, competitor assessments and business environmental assessment. DelveInsight is a knowledge partner for business strategy and market research across the drug value chain.

Download Free Report Summary PDF

Chronic Heart Failure - Epidemiology Insights to 2025 [Report Updated: 10-07-2017] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...

  • Allied Market Research
  • CBR Pharma
  • Current Partnering
  • Firstword
  • Global Data
  • Global Markets Direct
  • ICD Research
  • Infinti Research Technavio
  • Marketline
  • Markets and Markets
  • Micro Markets Monitor
  • MP Advisors
  • Venture Planning Group
  • GMR Data